Status:

COMPLETED

Dendritic Cell Cancer Vaccine for High-grade Glioma

Lead Sponsor:

Activartis Biotech

Conditions:

Glioblastoma Multiforme

Eligibility:

All Genders

3-70 years

Phase:

PHASE2

Brief Summary

A randomised, open-label, 2-arm, multi-centre, phase II clinical study with one group receiving standard therapy with Temozolomide, radiotherapy, and Trivax; and a control group receiving standard the...

Detailed Description

Vaccination represents a success story in modern medicine and its principles have been found to be valid in different species, at least in the case of infectious diseases. As of today, there is little...

Eligibility Criteria

Inclusion

  • Female or male, paediatric or adult patients of 3 to 70 years of age at time of diagnosis that qualify for standard treatment including surgery, Temozolomide and radiotherapy.
  • GBM (WHO IV), confirmed by histology.
  • Total, subtotal, or partial resection of more then 70% of tumour mass defined by MRI.
  • Supratentorial tumour localisation.
  • ECOG performance status 0, 1, or 2 (for study patients older 18 years).
  • Life expectancy of at least 12 weeks by assessment of the attending physician.
  • Written informed consent of patient and/or legal guardian in case of children or adolescents.

Exclusion

  • Less than 100 µg of tumour protein obtained from the resected tissue.
  • Anti-neoplastic chemotherapy or radiotherapy during 4 weeks before entering the study, e.g. in another therapeutic phase I, II, or III study.
  • Positive pregnancy test or breast-feeding.
  • Patients unwilling to perform a save method of birth control.
  • Known hypersensitivity to temozolomide.
  • HIV positivity.

Key Trial Info

Start Date :

April 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT01213407

Start Date

April 1 2010

End Date

November 1 2015

Last Update

May 19 2016

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Landesnervenklinik Wagner-Jauregg

Linz, Upper Austria, Austria, 4020

2

Landeskrankenhaus Feldkirch

Feldkirch, Austria, 6807

3

Department of Neurosurgery, Medical University Graz

Graz, Austria, 8036

4

Clinical Department of Neurology, Medical University Innsbruck

Innsbruck, Austria, 6020